Sulfamethoxazole, trimethoprim, isoniazid, pyridoxine (Isonoxale)
Sulfamethoxazole, trimethoprim, isoniazid, pyridoxine
Cipla Medpro (Pty) Ltd
Every registration of this product has been cancelled.
Registration
- Applicant
- Cipla Medpro (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Isonoxale Each Tablet contains: Sulfamethoxazole 800 mg; Trimethoprim 160,0 mg, Isoniazid 300,0 mg, Pyridoxine Hydrochloride 25,0 mg | Not listed | 520209.20852/20.2/0209.208 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Isoniazid
Consolidated Schedules 06 July 2026, line 6819
S4: Sulfamethoxazole
- except when registered in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947).
Consolidated Schedules 06 July 2026, lines 8032 to 8033
S4: Trimethoprim
- except when specifically intended and registered in combination with sulphonamides for the treatment of gastro-enteritis and pneumonia in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947).
Consolidated Schedules 06 July 2026, lines 8287 to 8289
S3: Vitamin b6
- and derivatives thereof
- in preparations thereof for injection; (S0)
- except in oral preparations or mixtures containing more than 100 mg of Vitamin B6 per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S1)
Consolidated Schedules 06 July 2026, lines 4421 to 4426
S1: Vitamin b6
- and derivatives thereof
- in oral preparations or mixtures containing more than 100 mg of Vitamin B6 per recommended daily dose alone or in combination with other active pharmaceutical ingredients; (S0)
- except in preparations thereof for injection. (S3)
Consolidated Schedules 06 July 2026, lines 1170 to 1175
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.